Previous Close | $16.00 |
Intrinsic Value | $0.00 |
Upside potential | -100% |
Data is not available at this time.
DENTSPLY SIRONA Inc. operates as a global leader in the dental consumables, equipment, and technology sector, serving dental professionals through a diversified portfolio of products and solutions. The company generates revenue primarily through the sale of dental implants, orthodontic appliances, imaging systems, and CAD/CAM solutions, catering to both general practitioners and specialists. Its market position is reinforced by a strong distribution network and strategic partnerships, enabling broad geographic reach and customer loyalty. DENTSPLY SIRONA competes in a fragmented but growing industry, driven by increasing demand for advanced dental care and digital dentistry solutions. The company’s focus on innovation, particularly in digital workflows and restorative materials, positions it as a key player in the transition toward more efficient and patient-centric dental practices. Despite competitive pressures, its established brand and comprehensive product suite provide a competitive edge in both developed and emerging markets.
In FY 2024, DENTSPLY SIRONA reported revenue of $3.79 billion, reflecting its scale in the dental industry. However, the company posted a net loss of $910 million, with diluted EPS of -$4.48, indicating significant challenges in profitability. Operating cash flow stood at $461 million, suggesting underlying operational efficiency, while capital expenditures of $180 million highlight ongoing investments in innovation and infrastructure.
The company’s negative earnings power in FY 2024 underscores operational headwinds, likely tied to restructuring costs or macroeconomic pressures. Free cash flow, calculated as operating cash flow minus capital expenditures, was $281 million, demonstrating some ability to generate liquidity despite profitability struggles. Capital efficiency metrics remain under scrutiny given the net loss and high debt levels.
DENTSPLY SIRONA’s balance sheet shows $272 million in cash and equivalents against total debt of $2.27 billion, indicating a leveraged position. The debt-to-equity ratio suggests financial risk, though operating cash flow provides some coverage. Investors should monitor debt servicing capabilities, especially if profitability does not improve in the near term.
Growth trends appear muted given the FY 2024 net loss, though the dental industry’s long-term prospects remain favorable. The company maintained a dividend of $0.64 per share, signaling commitment to shareholder returns despite earnings challenges. Future dividend sustainability will depend on profitability recovery and free cash flow generation.
Market expectations for DENTSPLY SIRONA likely reflect skepticism due to its FY 2024 losses. Valuation metrics may be depressed, with investors awaiting signs of turnaround. The stock’s performance will hinge on execution of cost-saving initiatives, demand for digital dentistry solutions, and broader macroeconomic conditions affecting dental spending.
DENTSPLY SIRONA’s strategic advantages include its global footprint, diversified product portfolio, and leadership in digital dentistry. The outlook depends on its ability to restore profitability, manage debt, and capitalize on industry tailwinds like aging populations and technological adoption. Success in these areas could reposition the company for sustainable growth.
Company filings, FY 2024 financial data
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |